Sunday, February 07, 2021 6:29:07 AM
- September 30: $50.2 M vs June 30: $58.3 M ... a $8.1 M decrease (9 months was "net" $25.6 M decrease)
- It is enough for "6" quarter, till end of 2021. Meanwhile the interim analysis will have extra cost, the CF-370 R&D will be "less" as
- No question: they will raise cash the "next" day of the interim result (The last raise was in May ... $52.5 million, before deducting underwriting discounts and commissions and estimated offering expenses Public Offering and approximately $3.0 million in a private placement transaction with Pfizer
Legitimacy:
- Pfizer invested 2 times, owns app 4%
- "13F" shares were 15.665 M (56.33%) ... Top five owns app. the 38%
- Insiders own app. 5%
All together: 65+%
like Amarin: I am fine with $25+ in Q2 based on interim announcement
Best,
G
Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM